Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects

NCT02560688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: DS-1040b
DRUG: Clopidogrel

Sponsor

Daiichi Sankyo